Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 294
Filtrar
1.
Aging (Albany NY) ; 13(9): 12733-12747, 2021 05 11.
Artigo em Inglês | MEDLINE | ID: mdl-33973530

RESUMO

While acknowledging carotid atherosclerosis (CAS) as a risk factor for ischemic stroke, reports on its pathogenesis are scarce. This study aimed to explore the potential mechanism of CAS through RNA-seq data analysis. Carotid intima tissue samples from CAS patients and healthy subjects were subjected to RNA-seq analysis, which yielded, 1,427 differentially expressed genes (DEGs) related to CAS. Further, enrichment analysis (Gene Ontology, KEGG pathway, and MOCDE analysis) was performed on the DEGs. Hub genes identified via the protein-protein interaction network (PPI) were then analyzed using TRRUST, DisGeNET, PaGenBase, and CMAP databases. Results implicated inflammation and immunity in the pathogenesis of CAS. Also, lung disease was associated with CAS. Hub genes were expressed in multiple diseases, mainly regulated by RELA and NFKB1. Moreover, three small-molecule compounds were found via the CMAP database for management of CAS; hub genes served as potential targets. Collectively, inflammation and immunity are the potential pathological mechanisms of CAS. This study implicates CeForanide, Chenodeoxycholic acid, and 0317956-0000 as potential drug candidates for CAS treatment.


Assuntos
Doenças das Artérias Carótidas/genética , Regulação da Expressão Gênica/imunologia , Mapas de Interação de Proteínas/genética , Doenças das Artérias Carótidas/tratamento farmacológico , Doenças das Artérias Carótidas/imunologia , Doenças das Artérias Carótidas/patologia , Estudos de Casos e Controles , Cefamandol/análogos & derivados , Cefamandol/farmacologia , Cefamandol/uso terapêutico , Ácido Quenodesoxicólico/farmacologia , Ácido Quenodesoxicólico/uso terapêutico , Biologia Computacional , Conjuntos de Dados como Assunto , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Voluntários Saudáveis , Humanos , Masculino , Pessoa de Meia-Idade , Mapas de Interação de Proteínas/efeitos dos fármacos , RNA-Seq , Túnica Íntima/patologia
2.
Int J Toxicol ; 39(3): 248-255, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32292075

RESUMO

Several pharmaceutical agents are known to produce ethanol intolerance, which is often depicted as disulfiram-like reaction. As in the case with disulfiram, the underlying mechanism is believed to be the accumulation of acetaldehyde in the blood, due to inhibition of the hepatic aldehyde dehydrogenases, albeit this has not been confirmed in all cases by blood acetaldehyde measurements. Herein, cefamandole, cotrimoxazole, griseofulvin, procarbazine, and propranolol, which are reported to produce a disulfiram-like reaction, as well as disulfiram, were administered to Wistar rats and the hepatic activities of ethanol metabolizing enzymes along with the levels of brain monoamines were determined. Blood acetaldehyde was also evaluated after ethanol administration in rats pretreated with the abovementioned pharmaceutical products. Disulfiram, cefamandole, and procarbazine significantly increased blood acetaldehyde levels after ethanol administration, while on the contrary, cotrimoxazole, griseofulvin, and propranolol had no effect on blood acetaldehyde. Interestingly, all substances used, except disulfiram, increased the levels of brain serotonin. According to our findings, cotrimoxazole, griseofulvin, and propranolol do not produce a typical disulfiram-like reaction, because they do not increase blood acetaldehyde when given together with ethanol. On the other hand, all tested agents share the common property to enhance brain serotonin, whereas a respective effect of ethanol is well established. Hence, the ethanol intolerance produced by these agents, whether blood acetaldehyde concentration is elevated or not, could be the result of a "toxic serotonin syndrome," as in the case of the concomitant use of serotonin-active medications that provoke clinical manifestations similar to those of a disulfiram reaction.


Assuntos
Acetaldeído/sangue , Encéfalo/efeitos dos fármacos , Cefamandol/farmacologia , Griseofulvina/farmacologia , Procarbazina/farmacologia , Propranolol/farmacologia , Serotonina/metabolismo , Combinação Trimetoprima e Sulfametoxazol/farmacologia , Inibidores de Acetaldeído Desidrogenases/farmacologia , Animais , Encéfalo/metabolismo , Dissulfiram/farmacologia , Masculino , Ratos Wistar
3.
Clin Microbiol Infect ; 19(9): 822-8, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23957786

RESUMO

The epidemiology of acute paediatric osteoarticular infections (OAI) has recently evolved, mainly due to the improvement of microbiological diagnosis. We conducted a prospective study to analyse the recent epidemiology and the clinical evolution of paediatric OAI in order to validate the adequacy of our probabilistic first-line antibiotic treatment (intraveinous cefamandole + gentamicin). All children suspected of community acquired OAI were included and followed-up for 3 years. The etiologic diagnosis was based on blood cultures, joint aspirations and bone punctures. All osteoarticular (OA) samples were systematically inoculated into blood culture bottles. Real-time universal 16S rRNA and PCR targeted on Staphylococcus aureus, Kingella kingae, Streptococcus pneumoniae and Streptococcus pyogenes were performed twice a week. From 17 March 2007 to 26 February 2009, 98 septic arthritis, 70 osteomyelitis, 23 osteoarthritis and six spondylodiscitis were analysed. A portal of entry was suspected in 44% of cases, including 55% of otorhinolaryngological infections. C reactive protein was the most sensitive inflammatory marker. PCR increased by 54% the performance of bacteriological diagnosis. Among the patients completely investigated (blood culture and OAI samples), there were 63% documented OAI. The main pathogens found were K. kingae (52%), S. aureus (28%), S. pyogenes (7%), S. pneumoniae (3%) and Streptococcus agalactiae (2%). All isolated bacteria were sensitive to the probabilist treatment and outcome was favorable. PCR has significantly improved the performance and the delay of IOA diagnosis in children, for which K. kingae turned out to be the first causative agent. The probabilistic treatment was active against the main bacteria responsible for paediatric OAI.


Assuntos
Artrite Infecciosa/microbiologia , Discite/microbiologia , Kingella kingae/isolamento & purificação , Osteoartrite/microbiologia , Osteomielite/microbiologia , Staphylococcus aureus/isolamento & purificação , Streptococcus/isolamento & purificação , Adolescente , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Artrite Infecciosa/diagnóstico , Artrite Infecciosa/tratamento farmacológico , Cefamandol/farmacologia , Cefamandol/uso terapêutico , Criança , Pré-Escolar , Discite/diagnóstico , Discite/tratamento farmacológico , Quimioterapia Combinada , Feminino , Gentamicinas/farmacologia , Gentamicinas/uso terapêutico , Humanos , Lactente , Recém-Nascido , Kingella kingae/efeitos dos fármacos , Kingella kingae/genética , Masculino , Osteoartrite/diagnóstico , Osteoartrite/tratamento farmacológico , Osteomielite/diagnóstico , Osteomielite/tratamento farmacológico , Reação em Cadeia da Polimerase , Estudos Prospectivos , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/genética , Streptococcus/genética , Streptococcus/crescimento & desenvolvimento , Streptococcus agalactiae/efeitos dos fármacos , Streptococcus agalactiae/genética , Streptococcus agalactiae/isolamento & purificação , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/isolamento & purificação , Streptococcus pyogenes/efeitos dos fármacos , Streptococcus pyogenes/genética , Streptococcus pyogenes/isolamento & purificação
4.
Int J Pharm ; 407(1-2): 197-206, 2011 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-21256942

RESUMO

Water mobility plays a crucial role in determining transport properties of small molecules in polymer matrices. In particular, in drug delivery systems, water state affects the pharmacokinetics, especially drug absorption, diffusion and release. In the present study, the state of water in an antibiotic-loaded composite consisting of albumin nanoparticles (BSA(np)) dispersed into a carboxylated polyurethane (PEUA) has been investigated and compared with that of the single drug-loaded components. The antibiotic cefamandole nafate was used as a model drug. DSC analysis, used to evaluate the freezing and non-freezing water fractions in the hydrated samples, showed that in BSA(np) water can adsorb both in the inter-particles regions and inside the particles. With increasing of total adsorbed water amount, the contribution of the freezing water fraction was higher than the non-freezing one. As for PEUA, the majority of water molecules absorbed is in a mobile freezing state (about 60% of the W(tot)). As for the PEUA/BSA(np) composite, the higher polyurethane phase segregation induced by the nanoparticles as well as the higher non-freezing water fraction significantly enhanced drug uptake with respect to PEUA. Moreover, the greater non-freezing water fraction allowed the drug to penetrate within BSA nanoparticles and to give rise then to a controlled drug release. Indeed, the diffusion barrier exerted by nanoparticles and the matrix prolonged the antimicrobial activity from 4 to 9 days. Finally, the higher polyurethane phase segregation also improved composite mechanical properties, as evidenced in stress-strain experiments and dynamic mechanical analysis.


Assuntos
Antibacterianos/administração & dosagem , Cefamandol/análogos & derivados , Soroalbumina Bovina/química , Água/química , Antibacterianos/farmacologia , Varredura Diferencial de Calorimetria , Cefamandol/administração & dosagem , Cefamandol/farmacologia , Preparações de Ação Retardada , Difusão , Congelamento , Testes de Sensibilidade Microbiana , Nanopartículas , Poliuretanos/química , Fatores de Tempo
5.
Antimicrob Agents Chemother ; 54(10): 4078-84, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20679509

RESUMO

Implant-related infections are serious complications of trauma and orthopedic surgery and are most difficult to treat. The bacterial biofilms of 34 clinical Staphylococcus sp. isolates (Staphylococcus aureus, n = 14; coagulase-negative staphylococci, n = 19) were incubated with daptomycin (DAP; 5, 25, or 100 mg/liter), vancomycin (VAN; 5, 25, or 100 mg/liter), tigecycline (TGC; 1, 5, or 25 mg/liter), fosfomycin (FOM; 100, 250, or 1,000 mg/liter), and cefamandole (FAM; 50, 100, or 500 mg/liter) for 24 h at three different ambient temperatures: 35°C, 40°C, and 45°C. To quantify the reduction of the biomass, the optical density ratio (ODr) of stained biofilms and the number of growing bacteria were determined. Increasing the temperature to 45°C or to 40°C during incubation with FAM, FOM, TGC, VAN, or DAP led to a significant but differential reduction of the thickness of the staphylococcal biofilms compared to that at 35°C (P < 0.05). Growth reduction was enhanced for DAP at 100 mg/liter at 35°C, 40°C, and 45°C (log count reductions, 4, 3.6, and 3.3, respectively; P < 0.05). A growth reduction by 2 log counts was detected for FAM at a concentration of 500 mg/liter at 40°C and 45°C (P = 0.01). FOM at 1,000 mg/liter reduced the bacterial growth by 1.2 log counts (not significant). The antibacterial activity of antimicrobial agents is significantly but differentially enhanced by increasing the ambient temperature and using high concentrations. Adjuvant hyperthermia may be of value in the treatment of biofilm-associated implant-related infections.


Assuntos
Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Cefamandol/farmacologia , Daptomicina/farmacologia , Fosfomicina/farmacologia , Minociclina/análogos & derivados , Staphylococcus/efeitos dos fármacos , Vancomicina/farmacologia , Minociclina/farmacologia , Tigeciclina
6.
Antimicrob Agents Chemother ; 53(8): 3437-41, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19487449

RESUMO

Methicillin (meticillin)-susceptible Staphylococcus aureus (MSSA) strains producing large amounts of type A beta-lactamase (Bla) have been associated with cefazolin failures, but the frequency and impact of these strains have not been well studied. Here we examined 98 MSSA clinical isolates and found that 26% produced type A Bla, 15% type B, 46% type C, and none type D and that 13% lacked blaZ. The cefazolin MIC(90) was 2 microg/ml for a standard inoculum and 32 microg/ml for a high inoculum, with 19% of isolates displaying a pronounced inoculum effect (MICs of >or=16 microg/ml with 10(7) CFU/ml) (9 type A and 10 type C Bla producers). At the high inoculum, type A producers displayed higher cefazolin MICs than type B or C producers, while type B and C producers displayed higher cefamandole MICs. Among isolates from hemodialysis patients with MSSA bacteremia, three from the six patients who experienced cefazolin failure showed a cefazolin inoculum effect, while none from the six patients successfully treated with cefazolin showed an inoculum effect, suggesting an association between these strains and cefazolin failure (P = 0.09 by Fisher's exact test). In summary, 19% of MSSA clinical isolates showed a pronounced inoculum effect with cefazolin, a phenomenon that could explain the cases of cefazolin failure previously reported for hemodialysis patients with MSSA bacteremia. These results suggest that for serious MSSA infections, the presence of a significant inoculum effect with cefazolin could be associated with clinical failure in patients treated with this cephalosporin, particularly when it is used at low doses.


Assuntos
Antibacterianos/farmacologia , Cefazolina/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Bacteriemia/tratamento farmacológico , Cefamandol/farmacologia , Cefazolina/uso terapêutico , Humanos , Meticilina/farmacologia , Testes de Sensibilidade Microbiana , Infecções Estafilocócicas/tratamento farmacológico , Falha de Tratamento , beta-Lactamases/metabolismo
7.
Eur J Pharm Sci ; 36(4-5): 555-64, 2009 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-19136061

RESUMO

Nano-structured polymers delivering an antibiotic for the prevention of medical device-related infections were developed. Systems consisted of bovine serum albumin or polyallylamine nanoparticles alone or entrapped in a polyurethane and then loaded with cefamandole nafate, chosen as a drug model. Results showed that nanoparticles alone were able to adsorb high antibiotic amounts due to their high surface/volume ratio. However, they released cefamandole in an uncontrolled fashion, leading to a rapid loss of antibacterial activity. Improvements in the release control were obtained when CEF loaded and non-loaded nanoparticles were entrapped in a carboxylated polyurethane. For these systems the drug delivery was at least of 50% with respect to nanoparticles alone with a prolonged antimicrobial activity up to 9 days.


Assuntos
Antibacterianos/administração & dosagem , Cefamandol/administração & dosagem , Nanopartículas , Poliaminas/química , Poliuretanos/administração & dosagem , Soroalbumina Bovina/química , Adsorção , Antibacterianos/química , Antibacterianos/farmacologia , Cefamandol/química , Cefamandol/farmacologia , Linhagem Celular Tumoral , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Testes de Sensibilidade Microbiana , Microscopia Eletrônica de Varredura , Poliuretanos/química
8.
Antimicrob Agents Chemother ; 51(8): 2733-40, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17548491

RESUMO

Antibiotic therapies to eradicate medical device-associated infections often fail because of the ability of sessile bacteria, encased in their exopolysaccharide matrix, to be more drug resistant than planktonic organisms. In the last two decades, several strategies to prevent microbial adhesion and biofilm formation on the surfaces of medical devices, based mainly on the use of antiadhesive, antiseptic, and antibiotic coatings on polymer surfaces, have been developed. More recent alternative approaches are based on molecules able to interfere with quorum-sensing phenomena or to dissolve biofilms. Interestingly, a newly purified beta-N-acetylglucosaminidase, dispersin B, produced by the gram-negative periodontal pathogen Actinobacillus actinomycetemcomitans, is able to dissolve mature biofilms produced by Staphylococcus epidermidis as well as some other bacterial species. Therefore, in this study, we developed new polymeric matrices able to bind dispersin B either alone or in combination with an antibiotic molecule, cefamandole nafate (CEF). We showed that our functionalized polyurethanes could adsorb a significant amount of dispersin B, which was able to exert its hydrolytic activity against the exopolysaccharide matrix produced by staphylococcal strains. When microbial biofilms were exposed to both dispersin B and CEF, a synergistic action became evident, thus characterizing these polymer-dispersin B-antibiotic systems as promising, highly effective tools for preventing bacterial colonization of medical devices.


Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/farmacologia , Biofilmes/efeitos dos fármacos , Cefamandol/análogos & derivados , Glicosídeo Hidrolases/farmacologia , Poliuretanos , Staphylococcus/efeitos dos fármacos , Antibacterianos/química , Proteínas de Bactérias/química , Biofilmes/crescimento & desenvolvimento , Cefamandol/química , Cefamandol/farmacologia , Linhagem Celular Tumoral , Interações Medicamentosas , Glicosídeo Hidrolases/química , Humanos , Testes de Sensibilidade Microbiana , Poliuretanos/química , Infecções Relacionadas à Prótese/prevenção & controle , Staphylococcus/crescimento & desenvolvimento , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus epidermidis/efeitos dos fármacos , Staphylococcus epidermidis/crescimento & desenvolvimento
9.
J Chemother ; 16(5): 446-52, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15565910

RESUMO

Acidic or basic polyurethanes were loaded with antibiotics to develop materials to prevent medical device-related infections. A correlation between polymer-antibiotic interactions and amount of drug absorbed by polymers and released over time was found. Since the employed antibiotics, i.e. amoxicillin, cefamandole nafate, rifampin and vancomycin, possessed at least an acidic group in their structural formula, the introduction of basic tertiary amines in the polyurethane side-chain resulted in an increased polymer ability to adsorb antibiotics. However, a stronger ionic interaction between this polymer and the antibiotics caused a release of lower amount of drug over time. Antibiotics released from polymers inhibited Staphylococcus epidermidis growth on agar. Antibiotic-loaded polyurethanes kept in water for increasing times were still able to show inhibition zones of bacterial growth. The antibacterial activity lasted up to 3 hours for amoxicillin, 24 hours for vancomycin, 8 days for cefamandole nafate and 8 months for rifampin.


Assuntos
Antibacterianos/farmacologia , Poliuretanos/química , Staphylococcus epidermidis/efeitos dos fármacos , Amoxicilina/química , Amoxicilina/farmacologia , Antibacterianos/administração & dosagem , Antibacterianos/química , Cefamandol/química , Cefamandol/farmacologia , Interações Medicamentosas , Humanos , Infusões Intravenosas , Testes de Sensibilidade Microbiana , Rifampina/química , Rifampina/farmacologia , Vancomicina/química , Vancomicina/farmacologia
10.
J Appl Microbiol ; 96(2): 244-53, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14723685

RESUMO

AIMS: To demonstrate that the nonlinear concentration-dependent inhibition of Pseudomonas aeruginosa to EDTA can be used to successfully model and predict the potentiation of antimicrobials by EDTA. METHODS AND RESULTS: A model used successfully to describe the concentration-dependent inhibition of bacterial growth caused by many antimicrobials was unable to describe the inhibition of P. aeruginosa by EDTA. Examination of the inhibition profiles for EDTA against P. aeruginosa revealed a biphasic inhibitory pattern suggesting different mechanisms of action at different concentrations. A modelled, two-stage inhibitory process was shown to fit the observations. This model was then used to examine the effect of combining EDTA with other antimicrobials. The apparent synergy of mixtures of EDTA with quaternary ammonium surfactants (QAC) and specific antibiotics was successfully modelled. Minimum inhibitory concentrations (MIC) of the QAC and that of oxacillin and cefamandole were reduced by a factor of 3-10, whereas ampicillin was reduced by a factor of 70 from an MIC of 1524 to 21 mg l(-1) in the presence of 500 mg l(-1) of EDTA. CONCLUSIONS: A nonlinear concentration-dependent inhibition of P. aeruginosa by EDTA gives rise to apparent observation of synergy with other antimicrobials. SIGNIFICANCE AND IMPACT OF THE STUDY: This is a further example where the current methodology for the examination of antimicrobial synergy (the summed fractional inhibitory concentrations) leads to false conclusions.


Assuntos
Antibacterianos/farmacologia , Quelantes/farmacologia , Quimioterapia Combinada/farmacologia , Ácido Edético/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Ampicilina/farmacologia , Cefamandol/farmacologia , Sinergismo Farmacológico , Testes de Sensibilidade Microbiana/métodos , Modelos Biológicos , Oxacilina/farmacologia , Compostos de Amônio Quaternário/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Tensoativos/farmacologia , Compostos de Trimetil Amônio
11.
Vet J ; 166(2): 170-6, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12902182

RESUMO

The pharmacokinetics and intramuscular (i.m.) bioavailability of cefoperazone and cefamandole (20mg/kg) were investigated in dogs and the findings related to minimal inhibitory concentrations (MICs) for 90 bacterial strains isolated clinically from dogs. The MICs of cefamandole for Staphylococcus intermedius (MIC(90) 0.125 microg/mL) were lower than those of cefoperazone (MIC(90) 0.5 micro/mL) although the latter was more effective against Escherichia coli strains (MIC(90) 2.0 microg/mL vs. 4.0 microg/mL). The pharmacokinetics of the drugs after intravenous administrations were similar: a rapid distribution phase was followed by a slower elimination phase (t((1/2)lambda2) 84.0+/-21.3 min for cefoperazone and 81.4+/-9.7 min for cefamandole). The apparent volume of distribution and body clearance were 0.233 L/kg and 1.96 mL/kg/min for cefoperazone, 0.190 L/kg and 1.76 mL/kg/min for cefamandole. After i.m. administration the bioavailability and peak serum concentration of cefamandole (85.1+/-13.5% and 35.9+/-5.4 microg/mL) were significantly higher than cefoperazone (41.4+/-7.1% and 24.5+/-3.0 micog/mL), but not the serum half-lives (t(1/2el) 134.3+/-12.6 min for cefoperazone and 145.4+/-12.3 min for cefamandole). The time above MIC(90) indicated that cefamandole can be administered once daily to dogs for the treatment of staphylococcal infections (T>MIC for S. intermedius 23.8+/-0.3 and for Staphylococcus aureus 21.6+/-0.6h).


Assuntos
Antibacterianos/farmacologia , Antibacterianos/farmacocinética , Cefamandol/farmacologia , Cefamandol/farmacocinética , Cefoperazona/farmacologia , Cefoperazona/farmacocinética , Animais , Disponibilidade Biológica , Cães , Feminino , Infusões Intravenosas , Injeções Intramusculares , Masculino , Testes de Sensibilidade Microbiana , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/veterinária , Staphylococcus/efeitos dos fármacos
12.
Biomaterials ; 24(19): 3221-7, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12763449

RESUMO

Failure to treat and eradicate prosthetic hip infection with systemic antibiotic regimens is usually due to the fact that the infection is associated with biofilm formation and that bacterial cells growing within a biofilm exhibit increased resistance to antimicrobial agents. In this in vitro study, we investigated the susceptibility of prosthetic hip Propionibacterium acnes and Staphylococcus spp. isolates growing within biofilms on polymethylmethacrylate (PMMA) bone cement to a range of antibiotics. All P. acnes isolates in the biofilm mode of growth demonstrated considerably greater resistance to cefamandole, ciprofloxacin and vancomycin. In contrast, only four of the eight P. acnes isolates demonstrated an increase in resistance to gentamicin. All ten Staphylococcus spp. isolates in the biofilm mode of growth exhibited large increases in resistance to gentamicin and cefamandole with eight of the ten isolates also exhibiting an increase in resistance to vancomycin. However, only three of the ten Staphylococcus spp. isolates exhibited an increase in resistance to ciprofloxacin. Biofilms were also formed on three different titanium alloys and on PMMA bone cement using P. acnes, Staphylococcus epidermidis and Staphylococcus aureus strains to determine if the underlying biomaterial surface had an effect on biofilm formation and the antimicrobial susceptibility of the bacteria growing within biofilms. Although differences in the rate at which the three strains adhered to the different biomaterials were apparent, no differences in biofilm antibiotic resistance between the biomaterials were observed. In the light of these results, it is important that the efficacy of other antibiotics against P. acnes and Staphylococcus spp. prosthetic hip isolates growing within biofilms on orthopaedic biomaterials be determined to ensure optimal treatment of orthopaedic implant infection.


Assuntos
Materiais Biocompatíveis/química , Biofilmes , Propionibacterium acnes/metabolismo , Ligas , Anti-Infecciosos/farmacologia , Aderência Bacteriana , Cimentos Ósseos/química , Cefamandol/farmacologia , Ciprofloxacina/farmacologia , Gentamicinas/farmacologia , Prótese de Quadril/microbiologia , Técnicas In Vitro , Polimetil Metacrilato/química , Fatores de Tempo , Titânio/química , Vancomicina/farmacologia
13.
Eur J Pharmacol ; 465(1-2): 1-7, 2003 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-12650826

RESUMO

Cephalosporin antibiotics are thought to be excreted into the urine via organic anion transporters (OATs) and OAT can mediate nephrotoxicity by cephalosporins, particularly by cephaloridine. The purpose of this study was to elucidate the interaction of human-OAT2 and rat-OAT2 with cephalosporin antibiotics using proximal tubule cells stably expressing human-OAT2 and rat-OAT2. Human-OAT2 is localized to the basolateral side of the proximal tubule, whereas rat-OAT2 is localized to the apical side of the proximal tubule. Cephalosporins tested were cephalothin, cefoperazone, cefazolin, ceftriaxone, cephaloridine, cefotaxime, cefadroxil and cefamandole. These cephalosporins dose-dependently inhibited organic anion uptake mediated by human-OAT2 and rat-OAT2. There was no species difference observed for the effects of OAT2 with cephalosporins between human and rat transporters. Kinetic analysis revealed that the inhibitory effects for human-OAT2 were competitive. Cephaloridine significantly decreased the viability of cells stably expressing human-OAT2, human-OAT1, human-OAT3 and human-OAT4. The decreased viability of cells stably expressing human-OAT1, human-OAT3 and human-OAT4 but not human-OAT2 was reversed by probenecid. In conclusion, human-OAT2 interacts with cephalosporins, and thus, human-OAT2 may mediate the uptake of cephalosporins on the basolateral side of the proximal tubule. The interaction of human-OAT2 with cephalosporins was the weakest among the basolateral human-OATs tested. In addition, it is suggested that human-OATs mediate cephaloridine-induced nephrotoxicity.


Assuntos
Antibacterianos/farmacologia , Cefalosporinas/farmacologia , Transportadores de Ânions Orgânicos Sódio-Independentes/metabolismo , Animais , Transporte Biológico/efeitos dos fármacos , Cefadroxila/farmacologia , Cefamandol/farmacologia , Cefazolina/farmacologia , Cefoperazona/farmacologia , Cefotaxima/farmacologia , Ceftriaxona/farmacologia , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Cefaloridina/farmacologia , Cefalotina/farmacologia , Dinoprosta/farmacocinética , Relação Dose-Resposta a Droga , Humanos , Cinética , Camundongos , Camundongos Transgênicos , Transportadores de Ânions Orgânicos Sódio-Independentes/genética , Probenecid/farmacologia , Ratos , Transfecção , Uricosúricos/farmacologia
14.
J Antimicrob Chemother ; 46 Suppl T2: 1-8, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11065144

RESUMO

Communicating information from antimicrobial resistance surveillance study data to microbiologists and physicians can be challenging. Large amounts of data, commonly reaching millions of MICs or zone diameter endpoints, must be analysed and condensed to easily-read tables or figures. Furthermore, data must not be prejudged relative to susceptibility categories, because of the diverse nature of interpretive criteria available internationally. An attempt must be made to present results of all surveillance studies in a mode that can be reinterpreted for immediate use in different geographical areas, or used to compare future data with relative ease and high accuracy. Such data displays require peer-reviewed journals to permit greater numbers of more complex tables to present results. The Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) study is a year-on-year global surveillance programme in medical centres where meropenem is available for use. We have developed a presentation strategy that expands the long-term clinical value of MYSTIC results. In addition to statistical parameters, tables of cumulative percentages or numbers of strains inhibited at each tested antimicrobial concentration will be presented. Alternative figures (Finland-o-grams) could also be used, but these generally lack precise extractable rates and require more journal space. Regardless of study design, promotion of this presentation philosophy enhances any surveillance study's value to each reader or user and facilitates application to locally appropriate interpretations. The widespread use of these analysis and presentation principles as benchmarks by various resistance studies and networks is strongly encouraged, particularly by investigations across international boundaries.


Assuntos
Antibacterianos/farmacologia , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Tienamicinas/farmacologia , Cefamandol/farmacologia , Cefalosporinas/farmacologia , Coleta de Dados , Resistência Microbiana a Medicamentos , Humanos , Estudos Longitudinais , Meropeném , Testes de Sensibilidade Microbiana/métodos
15.
Ann Fr Anesth Reanim ; 19(7): 540-3, 2000 Aug.
Artigo em Francês | MEDLINE | ID: mdl-10976369

RESUMO

A 87-year-old patient developed coagulation abnormality following hip surgery related to the prophylactic use of cefamandole. Cefamandole as others cephalosporins with a methyl-tetrazol-thiol lateral chain interferes with the vitamin K regeneration cycle as do oral anticoagulants. Therefore, the use of others antibiotics or systematic vitamin K1 supplementation or single dose of cefamandole is recommended for patients with renal failure or with malnutrition. Vitamin K1 supplementation is a simple method resulting in complete resolution of the coagulation disorder.


Assuntos
Antibioticoprofilaxia/efeitos adversos , Artroplastia de Quadril , Cefamandol/efeitos adversos , Cefalosporinas/efeitos adversos , Transtornos Hemorrágicos/induzido quimicamente , Complicações Pós-Operatórias/induzido quimicamente , Deficiência de Vitamina K/induzido quimicamente , Idoso , Idoso de 80 Anos ou mais , Cefamandol/administração & dosagem , Cefamandol/farmacologia , Cefalosporinas/administração & dosagem , Cefalosporinas/farmacologia , Feminino , Fraturas do Colo Femoral/cirurgia , Hematoma/etiologia , Transtornos Hemorrágicos/tratamento farmacológico , Humanos , Complicações Pós-Operatórias/tratamento farmacológico , Vitamina K/antagonistas & inibidores , Vitamina K/uso terapêutico , Deficiência de Vitamina K/tratamento farmacológico
16.
J Antimicrob Chemother ; 43(1): 55-60, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10381101

RESUMO

Seven beta-lactam antibiotics (cefepime, cefoperazone, ceftazidime, ceftriaxone, cefamandole, imipenem and meropenem) were tested for their potential to select resistance in standard and clinical strains of Enterobacter cloacae (n = 9). The strains were subcultured daily with the test antibiotics at doubling concentrations starting at 0.125 x MIC. Development of resistance throughout the passages was detected by a disc diffusion test. Ceftazidime, ceftriaxone and cefamandole selected resistance at a faster rate than cefoperazone, cefepime and meropenem. Imipenem did not select resistance in the nine strains tested and was the only antibiotic that eradicated all the strains during selection. The resistance patterns of strains selected by meropenem, cefepime and the other cephalosporins were markedly different, although cross-resistance to the early generation cephalosporins was common. The resistance phenotypes of most strains remained stable upon serial passages in antibiotic-free medium. The findings of this study highlight the importance of the choice of antibiotic for therapy not only on the basis of its antibacterial activity, but also on its potential to select resistance to itself and other antibiotics.


Assuntos
Antibacterianos/farmacologia , Enterobacter cloacae/efeitos dos fármacos , Resistência beta-Lactâmica , Cefamandol/farmacologia , Cefepima , Cefoperazona/farmacologia , Ceftazidima/farmacologia , Ceftriaxona/farmacologia , Cefalosporinas/farmacologia , Resistência Microbiana a Medicamentos , Imipenem/farmacologia , Meropeném , Testes de Sensibilidade Microbiana , Tienamicinas/farmacologia
17.
J Antimicrob Chemother ; 43(2): 291-4, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11252338

RESUMO

The bactericidal activity in vitro of cefpirome plus either vancomycin or teicoplanin was compared with that of a cefamandole-vancomycin combination against ten clinical isolates of homogeneous methicillin-resistant Staphylococcus aureus. Cefpirome (0.125 x MIC) combined with vancomycin (0.5-2 x MIC) or teicoplanin (0.5-4 x MIC) acted synergically against the ten isolates. Similar effects were observed with the cefamandole-vancomycin combination, except that for one isolate, higher cefamandole concentrations (0.25-1 x MIC) were required.


Assuntos
Antibacterianos/farmacologia , Cefamandol/farmacologia , Cefalosporinas/farmacologia , Quimioterapia Combinada/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Resistência a Meticilina , Testes de Sensibilidade Microbiana , Teste Bactericida do Soro , Teicoplanina/farmacologia , Vancomicina/farmacologia , Cefpiroma
18.
Antimicrob Agents Chemother ; 42(11): 3002-5, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9797241

RESUMO

The susceptibilities of 49 isolates recovered from orthopedic implants to seven antimicrobial agents were evaluated by the broth microdilution method. Ciprofloxacin and vancomycin were more active than gentamicin, representing aminoglycosides which are routinely incorporated into bone cement, and also more active than the peroperative antimicrobial agents cefamandole and erythromycin. The use of ciprofloxacin and vancomycin in vivo, therefore, warrants further evaluation.


Assuntos
Antibacterianos/farmacologia , Artroplastia de Quadril/efeitos adversos , Bactérias/efeitos dos fármacos , Cefamandol/farmacologia , Ciprofloxacina/farmacologia , Eritromicina/farmacologia , Humanos , Testes de Sensibilidade Microbiana , Vancomicina/farmacologia
19.
Chemotherapy ; 44(5): 324-7, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9732147

RESUMO

Aim of the present study was to evaluate the effect of cefamandole, cefuroxime and cefoxitin on the level of gastrointestinal (GI) colonization by Candida albicans in humans. Twenty-eight adult patients received one of these three cephalosporins for 10 days, as treatment of infection, and were studied prospectively. Quantitative stool cultures for yeasts were performed immediately before, at the end, and 1 week after discontinuation of treatment. All three antibiotics caused an increase of the yeast concentration in the fecal flora. The increase caused by cefoxitin was the highest (2.5 log10 CFU/g of stool). Our results suggest that the cephalosporins tested cause minor increases of the colonization of the GI tract by C. albicans.


Assuntos
Candida albicans/efeitos dos fármacos , Cefamandol/farmacologia , Cefoxitina/farmacologia , Cefuroxima/farmacologia , Cefalosporinas/farmacologia , Cefamicinas/farmacologia , Fezes/microbiologia , Adulto , Idoso , Candida albicans/crescimento & desenvolvimento , Candidíase/etiologia , Contagem de Colônia Microbiana , Sistema Digestório/microbiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Operatório
20.
J Infect Dis ; 177(1): 146-54, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9419181

RESUMO

Beta-lactams active against methicillin-resistant Staphylococcus aureus (MRSA) must resist penicillinase hydrolysis and bind penicillin-binding protein 2A (PBP 2A). Cefamandole might share these properties. When tested against 2 isogenic pairs of MRSA that produced or did not produce penicillinase, MICs of cefamandole (8-32 mg/L) were not affected by penicillinase, and cefamandole had a > or =40 times greater PBP 2A affinity than did methicillin. In rats, constant serum levels of 100 mg/L cefamandole successfully treated experimental endocarditis due to penicillinase-negative isolates but failed against penicillinase-producing organisms. This suggested that penicillinase produced in infected vegetations might hydrolyze the drug. Indeed, cefamandole was slowly degraded by penicillinase in vitro. Moreover, its efficacy was restored by combination with sulbactam in vivo. Cefamandole also uniformly prevented MRSA endocarditis in prophylaxis experiments, a setting in which bacteria were not yet clustered in the vegetations. Thus, while cefamandole treatment was limited by penicillinase, the drug was still successful for prophylaxis of experimental MRSA endocarditis.


Assuntos
Proteínas de Bactérias , Cefamandol/uso terapêutico , Cefalosporinas/uso terapêutico , Endocardite/tratamento farmacológico , Hexosiltransferases , Penicilinase/metabolismo , Peptidil Transferases , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/enzimologia , Animais , Antibacterianos/farmacologia , Proteínas de Transporte/análise , Proteínas de Transporte/metabolismo , Cefamandol/administração & dosagem , Cefamandol/farmacologia , Cefalosporinas/administração & dosagem , Cefalosporinas/farmacologia , Endocardite/enzimologia , Endocardite/metabolismo , Resistência a Meticilina , Testes de Sensibilidade Microbiana , Muramilpentapeptídeo Carboxipeptidase/análise , Muramilpentapeptídeo Carboxipeptidase/metabolismo , Proteínas de Ligação às Penicilinas , Ratos , Infecções Estafilocócicas/enzimologia , Infecções Estafilocócicas/metabolismo , Staphylococcus aureus/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...